The use of prophylactic antibiotics for percutaneous K-wires in orthopaedic surgery - Antibiotic usage with percutaneous K-wires

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-011342-26-GB

Enrollment

100

Registered

2009-09-04

Start date

2009-11-12

Completion date

Unknown

Last updated

2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

INfection following k-wire insertion

Interventions

Trade Name: Flucloxacillin (1g) Inj Product Name: Flucloxacillin Product Code: PL 24610/0009 Pharmaceutical Form: Injection* Trade Nam

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients requiring percutaneous K-wires during their orthopaedic surgery will be invited to participate. Patients who are unable to understand the patient information leaflet and provide a valid consent will be excluded. Are the trial subjects under 18? Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Patients will also be excluded if there is a proven high risk of infection e.g. patients with an open, contaminated wounds, poor local skin condition, immunosuppresed patients, and other co-morbidities which may increase the possibility of an infection.

Design outcomes

Primary

Measure	Time frame
Main Objective: To determine whether the incidence of local infection is reduced in patients who are administered prophylactic antibiotics with percutaneous K-wires for clean orthopaedic surgery.;Secondary Objective: Do we need to give antibiotics to patients who need percutaneous K-wires?;Primary end point(s): To determine whether the incidence of local infection is reduced in patients who are administered prophylactic antibiotics with percutaneous K-wires for clean orthopaedic surgery.	—

Measure

Time frame

Main Objective: To determine whether the incidence of local infection is reduced in patients who are administered prophylactic antibiotics with percutaneous K-wires for clean orthopaedic surgery.;Secondary Objective: Do we need to give antibiotics to patients who need percutaneous K-wires?;Primary end point(s): To determine whether the incidence of local infection is reduced in patients who are administered prophylactic antibiotics with percutaneous K-wires for clean orthopaedic surgery.

—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026